What's happening
This bill creates a fund to support patient access to and education about clinical trials for life-threatening or disabling conditions in New York.
Why it matters
Addresses barriers to clinical trial participation. By funding transportation, lodging, and patient navigation services, the bill targets key obstacles—such as travel costs and administrative complexity—that often prevent patients from accessing potentially life-saving or life-improving experimental treatments.
Prioritizes support for vulnerable populations. The bill is designed to help patients with life-threatening or disabling conditions, who are often underrepresented in clinical trials, thereby promoting more equitable access to cutting-edge medical research.
Increases awareness and informed participation. By supporting outreach and education for patients, families, and healthcare providers, the bill aims to ensure that more people are aware of relevant clinical trials and understand how to enroll, potentially improving health outcomes and advancing medical knowledge.
Promotes accountability and program effectiveness. Annual reporting requirements for grant recipients and a competitive application process help ensure that funds are used effectively and that the program is responsive to the needs of New Yorkers seeking clinical trial participation.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
- Likely support
Patients with life-threatening or disabling conditions or diseases
Grants could support transportation, lodging, education and navigation services to help them access clinical trials and address insurance or other enrollment barriers.
Medical schools, hospitals and health care provider organizations
Eligible institutions could compete for grants to provide clinical trial access and education services.
Patient-focused nonprofits, local health departments and municipalities
These eligible applicants could seek grants, with preference given to those experienced in serving these patients and providing outreach, education and health care navigation.
New York State Department of Health
The department would administer the fund subject to appropriations, establish a competitive grant application process and require annual reports from grantees.
Headline styles
Fund Patient Clinical Trial Access
Plain English, a few words. Used as the page title.
Sponsors
16 Co-sponsors
1 Multi-sponsor
History
- Referred to ways and means
- Reported referred to ways and means
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Fund Clinical Trial Access
In Senate Committee · Health · Sponsor Gustavo Rivera
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
1035
2019-2020 Regular Sessions
IN ASSEMBLY
January 14, 2019
Introduced by M. of A. GOTTFRIED, PAULIN, GUNTHER, L. ROSENTHAL, CAHILL, GALEF, ENGLEBRIGHT, JAFFEE, ZEBROWSKI, LUPARDO, ABINANTI, PERRY, WEPRIN, D'URSO -- Multi-Sponsored by -- M. of A. CARROLL -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to establishing the clinical trial access and education fund
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 2424 to read as follows:
§ 2424. Clinical trial access and education fund. 1. Definitions. For the purposes of this section, the following terms shall have the following meanings:
a. "Eligible applicant" means (i) a medical school that sponsors a clinical trial, (ii) a not-for-profit organization with experience and expertise working with patients with life-threatening or disabling conditions or diseases, (iii) a health care provider organization, association or society, (iv) a general hospital defined in article twentyeight of this chapter, (v) a county or city health department, or (vi) a municipality.
b. "Clinical trial" shall have the same meaning as in subdivision two-b of section forty-nine hundred of this chapter.
2. Establishment of fund. There is hereby established within the department a clinical trial access and education fund. Subject to appropriations, the department shall provide grants to eligible applicants on a competitive request for proposal basis to provide one or more of the following services to patients with life-threatening or disabling conditions or diseases, as such terms are defined in section forty-nine hundred of this chapter, to facilitate access to or education on clinical trials of treatments for the patient's condition or disease:
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD03367-01-9
A. 1035 2
a. transportation services and lodging to provide patients with access to clinical trials or other related treatments while enrolled in a clinical trial or to access testing and other services to determine patient eligibility for a clinical trial;
b. patient outreach and education services to educate patients, their families and health care providers about the existence of and how patients may enroll in clinical trials, under section two hundred seven of this chapter; and
c. patient navigation services to help patients to determine if they are eligible for clinical trials, to help patients to enroll in clinical trials and to assist patients in dealing with insurance or other issues which serve as barriers to patient enrollment in clinical trials.
3. Applications. The commissioner shall establish an application process by which eligible applicants may apply for a grant under this section. The application shall include:
a. the geographic area in which the services shall be provided;
b. a detailed description of the services to be provided;
c. applicant's experience working with patients with life-threatening or disabling conditions or diseases;
d. applicant's ability to provide patient outreach or clinical trial education and navigation services, or coordinate or provide transportation and lodging for patients; and
e. any other information that the commissioner deems relevant and appropriate.
The commissioner shall give preference to eligible applicants who have experience and expertise working with patients with life-threatening or disabling conditions or diseases and providing patient outreach, education and health care navigation services.
4. Reports. Grantees shall file an annual report with the commissioner, in such form and with such information and data as the commissioner prescribes detailing the expenditure of grant funds and summarizing the efforts undertaken to increase patient access to clinical trials.
5. The commissioner shall make regulations reasonably necessary to implement the provisions of this section.
§ 2. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.